Impact of Nebulized Verapamil in Patients with Pulmonary Hypertension Secondary to Lung Diseases

Background: Pulmonary hypertension (PH) secondary to chronic lung diseases (CLD) remains a major therapeutic challenge, as systemic vasodilators may aggravate ventilation–perfusion mismatch and worsen hypoxemia. Inhaled therapy offers the potential for selective pulmonary vasodilation with minimal s...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Tamer Ibraheem, Amr Shawky, Mai Samy Azab, Dalia Abd El Sattar El Embaby
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Ain Shams University; Faculty of Medicine. Ain Shams Clinical and Scientific Society 2026-05-01
Edice:	Ain Shams Medical Journal
Témata:	Pulmonary hypertension chronic lung disease verapamil inhalation therapy calcium channel blocker
On-line přístup:	https://asmj.journals.ekb.eg/article_506967.html
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!